137 results
Page 3 of 7
8-K
EX-99.1
tiwf7upx13kpnyl
2 Dec 21
Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104
7:17am
8-K
EX-99.1
vxyrkund
15 Nov 21
Acasti Pharma Announces Annual Stock Option Grants
12:00am
424B5
6a4bohggn0yzul09e
10 Nov 21
Prospectus supplement for primary offering
7:23am
8-K
EX-99.1
nndic
10 Nov 21
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2022
7:09am
8-K
EX-99.1
1djaqhd9hln dszp823g
22 Sep 21
Acasti Pharma Provides Update Following Acquisition of Grace Therapeutics and Regains Compliance with Nasdaq Listing Standards
8:30am
8-K
EX-99.2
0en16i2y vfgvr0
27 Aug 21
Completion of Acquisition or Disposition of Assets
8:47am
425
EX-99.1
c2jxjkhz8n vy5wbiwxd
12 Aug 21
Business combination disclosure
11:00am
425
q15zjkm63xvj2 nspy
12 Aug 21
Business combination disclosure
11:00am
8-K
nirh8t 9nid7q
12 Aug 21
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2022
10:57am
8-K
EX-99.1
u6x9c8 f327
12 Aug 21
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2022
10:57am
425
1tn12 59qtkjltt
4 Aug 21
Business combination disclosure
5:03pm
425
jjcc7f
4 Aug 21
Business combination disclosure
5:00pm
8-K
6mf35ugyq87
23 Jul 21
Other Events
8:43am
8-K
EX-99.1
wrwhk djhl
23 Jul 21
Other Events
8:43am
425
EX-99.1
s3t 22onqzd4i
23 Jul 21
Business combination disclosure
8:41am
425
y5h7j 11ei8
23 Jul 21
Business combination disclosure
8:41am
8-K
wzz00
21 Jul 21
Other Events
5:17pm
425
1jv91nf
21 Jul 21
Business combination disclosure
5:15pm